Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Interest Expenses (2022 - 2025)

Historic Interest Expenses for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $1.5 million.

  • TriSalus Life Sciences' Interest Expenses rose 2784.59% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 15481.48%. This contributed to the annual value of $3.1 million for FY2024, which is 1921250.0% up from last year.
  • According to the latest figures from Q3 2025, TriSalus Life Sciences' Interest Expenses is $1.5 million, which was up 2784.59% from $1.4 million recorded in Q2 2025.
  • TriSalus Life Sciences' 5-year Interest Expenses high stood at $1.5 million for Q3 2025, and its period low was $1000.0 during Q4 2022.
  • Over the past 4 years, TriSalus Life Sciences' median Interest Expenses value was $441000.0 (recorded in 2023), while the average stood at $599916.7.
  • Per our database at Business Quant, TriSalus Life Sciences' Interest Expenses tumbled by 4000.0% in 2024 and then skyrocketed by 4020000.0% in 2025.
  • Quarter analysis of 4 years shows TriSalus Life Sciences' Interest Expenses stood at $1000.0 in 2022, then surged by 200.0% to $3000.0 in 2023, then soared by 35500.0% to $1.1 million in 2024, then surged by 36.7% to $1.5 million in 2025.
  • Its Interest Expenses was $1.5 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.2 million in Q1 2025.